文献速递精神分裂症与精神病性障碍

精神分裂症的功能磁共振成像:当前证据、方法学进展、局限性与未来方向

Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions.
PubMed 文献 · World Psychiatry · 2024-01-01

本文全面综述了精神分裂症功能磁共振成像(fMRI)研究,涵盖从病例对照的局部脑激活到全局连接及机器学习等分析方法的演变,并回顾了阴性症状、神经认知与社会认知缺陷的fMRI标记,以及抗精神病药、心理治疗和神经调控相关研究。综述指出,为使fMRI具有临床实用性,研究应针对精神分裂症治疗中的常规可操作临床决策,并需权衡成本与可及性。

要点

  • fMRI研究已从局部激活转向全局连接和机器学习以识别预测性特征。
  • 阴性症状及认知缺陷的功能神经标记是有潜力的治疗靶点。
  • fMRI临床转化需针对常规治疗决策并考虑成本与可及性。

核心结论

  • 为使fMRI在精神分裂症患者照护中具有临床实用性,研究应针对常规治疗中可操作的临床决策,如抗精神病药选择或功能损害预测。
  • fMRI的潜在临床效用受成本与可及性因素影响,必须权衡评估。
  • 未来评估fMRI在预后和治疗反应中的效用时,可考虑纳入卫生经济学分析。

研究设计与样本

  • 本文为综述,系统回顾和批判性总结了精神分裂症功能神经影像特别是fMRI的文献。
  • 综述范围涵盖从病例对照研究到机器学习算法、治疗相关研究及方法学进展。

主要发现

  • fMRI研究已从病例对照的局部脑激活转向全局连接和先进分析方法,并应用机器学习识别预测性神经影像特征。
  • 阴性症状以及神经认知和社会认知缺陷的fMRI研究提示功能神经标记可能是有潜力的治疗靶点。
  • fMRI研究涉及抗精神病药、心理治疗和社会心理干预及神经刺激的治疗反应、抵抗、机制和靶点选择。
  • fMRI和数据驱动方法可用于剖析精神分裂症的异质性,超越病例对照比较。

临床怎么用

  • 临床应关注fMRI能否辅助常规治疗决策,如抗精神病药选择或预测患者是否可能出现持续功能损害。
  • 应用fMRI需权衡成本与可及性,并考虑卫生经济学证据。

局限性

  • fMRI在精神分裂症中面临挑战和批评,最突出的是缺乏临床转化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Functional neuroimaging emerged with great promise and has provided fundamental insights into the neurobiology of schizophrenia. However, it has faced challenges and criticisms, most notably a lack of clinical translation. This paper provides a comprehensive review and critical summary of the literature on functional neuroimaging, in particular functional magnetic resonance imaging (fMRI), in schizophrenia. We begin by reviewing research on fMRI biomarkers in schizophrenia and the clinical high risk phase through a historical lens, moving from case-control regional brain activation to global connectivity and advanced analytical approaches, and more recent machine learning algorithms to identify predictive neuroimaging features. Findings from fMRI studies of negative symptoms as well as of neurocognitive and social cognitive deficits are then reviewed. Functional neural markers of these symptoms and deficits may represent promising treatment targets in schizophrenia. Next, we summarize fMRI research related to antipsychotic medication, psychotherapy and psychosocial interventions, and neurostimulation, including treatment response and resistance, therapeutic mechanisms, and treatment targeting. We also review the utility of fMRI and data-driven approaches to dissect the heterogeneity of schizophrenia, moving beyond case-control comparisons, as well as methodological considerations and advances, including consortia and precision fMRI. Lastly, limitations and future directions of research in the field are discussed. Our comprehensive review suggests that, in order for fMRI to be clinically useful in the care of patients with schizophrenia, research should address potentially actionable clinical decisions that are routine in schizophrenia treatment, such as which antipsychotic should be prescribed or whether a given patient is likely to have persistent functional impairment. The potential clinical utility of fMRI is influenced by and must be weighed against cost and accessibility factors. Future evaluations of the utility of fMRI in prognostic and treatment response studies may consider including a health economics analysis.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Voineskos AN, Hawco C, Neufeld NH, et al. Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions. World Psychiatry. 2024. PMID: 38214624. doi:10.1002/wps.21159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。